CORRESP: Correspondence
Published on December 2, 2025
Profound Medical Corp.
2400 Skymark Avenue, Unit #6
Mississauga, Ontario L4W 5K5
December 2, 2025
VIA EDGAR
U.S. Securities and Exchange Commission
Division of Corporation Finance
100 F Street, N.E.
Washington, D.C. 20549
| Re: | Profound Medical Corp. |
| Registration Statement on Form S-3 | |
| Filed November 13, 2025 | |
| File No. 333-291516 | |
| Acceleration Request |
Ladies and Gentlemen:
In accordance with Rule 461 of the Rules and Regulations promulgated under the Securities Act of 1933, as amended, Profound Medical Corp., a corporation existing under the laws of Ontario, Canada (the “Registrant”), hereby respectfully requests that the Securities and Exchange Commission accelerate the effective date of the above-referenced Registration Statement on Form S-3 to Thursday, December 4, 2025, at 4:30 p.m., Eastern time, or as soon as thereafter practicable.
The cooperation of the staff in meeting the timetable described above is very much appreciated.
Please contact Jeffrey P. Schultz of Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, P.C., counsel to the Registrant, at (212) 692-6732 with any questions regarding this request.
| Very truly yours, | |
| PROFOUND MEDICAL CORP. | |
| /s/ Rashed Dewan | |
| Rashed Dewan | |
| Chief Financial Officer |
| cc: | Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, P.C. |
| Jeffrey P. Schultz | |
| Cheryl V. Reicin | |
| Eric Foster |